Join ReciBioPharm at the 2nd mRNA Process Development & Manufacturing Summit, September 26-28, 2023, Boston
ReciBioPharm combines the capabilities of CDMOs Arranta Bio, GenIbet, and Vibalogics as a trusted partner for biologics drug development and manufacturing services.
With our expanded portfolio of cutting-edge technologies and expertise, we offer a comprehensive suite of solutions to accelerate the production of complex therapeutics such as plasmid DNA, RNA-based therapies, viral-based vaccines, and microbiome live biotherapeutics.
Innovation is at the heart of ReciBioPharm, exploring uncharted territories in drug development. By forging strategic partnerships with leading biotech companies, we accelerate the translation of scientific discoveries into tangible clinical solutions.
Every breakthrough, drug candidate, and therapeutic innovation we help develop is driven by a commitment to improving human health. We aim to transform the lives of patients worldwide and drive meaningful impact across the healthcare landscape.
Meet us at the 2nd mRNA Process Development & Manufacturing Summit to discover first-hand how we are shaping the future of medicine and empowering healthcare providers with ground-breaking therapies that revolutionize the way we approach drug development.
Join our expert Jing Zhu on Wednesday 27 September at 2.30pm when he presents “Accelerating mRNA Clinical Development from Start to Finish” during the presentation he will cover:
- Reducing lead times and cost for mRNA production with a new plasmid downstream process platform
- Taking a phase-appropriate strategy to facilitate mRNA development and production
- Using a toolbox approach to address various challenges during mRNA purification